Future Health Names Three Solutions for Spotting Disease Risk Earlier
Future Health, an Abu Dhabi-backed global initiative, has named three winning solutions with MIT Solve that help health systems detect disease risks sooner. ThinkMD won the grand prize, while VectorCam and Huna were named distinguished finalists.
Future Health, a global health initiative led by Abu Dhabi, has named three winning solutions together with MIT Solve, a programme of the Massachusetts Institute of Technology, in a challenge on anticipatory health systems. Such systems aim to let authorities act before an illness turns into an outbreak or crisis. The article is sponsored content written by Future Health itself.
The Future Health Impact Challenge drew 393 submissions from 68 countries. ThinkMD took the grand prize, while VectorCam and Huna were recognised as distinguished finalists. The challenge sought practical solutions with evidence of impact and the potential to scale.
Three approaches
ThinkMD has built an offline mobile platform that guides frontline health workers through structured patient assessments where doctors and diagnostic tools are scarce. Almost 10,000 workers across 885 facilities use it. In Zambia, analysis of around one million encounters revealed symptom patterns several months before a confirmed cholera outbreak. In Kenya, deployment data showed improvements in spotting danger signs in infants and in correctly prescribing antibiotics for childhood pneumonia.
VectorCam uses a low-cost smartphone imaging device and offline artificial intelligence so community health workers can photograph and identify mosquitoes. The time and location data help authorities see changing vector risk. Field evaluations show data completeness rising from about 60% to more than 90%.
Huna analyses routine complete blood count data to find people at elevated cancer risk and prioritise them for screening. The platform does not diagnose cancer from a blood test; it helps direct limited screening capacity. In Brazil, its deployments have screened more than 500,000 people and detected hundreds of cancer cases.
Challenges of scaling
The organisers stress that a successful pilot is not the same as system-wide impact. Scaling requires local validation, integration into existing workflows, responsible data governance, sustainable financing, workforce training, and evidence that earlier insight changes decisions and outcomes.
